India's Morepen Laboratories Produces Test Batch Of Sputnik V Vaccine - RDIF
Faizan Hashmi 3 months ago Tue 06th July 2021 | 01:50 PM
MOSCOW (UrduPoint News / Sputnik - 06th July, 2021) The Russian Direct Investment Fund (RDIF) announced on Tuesday the production of a pilot batch of Russia's Sputnik V COVID-19 vaccine in India jointly with Indian pharmaceutical manufacturer Morepen Laboratories.
"The Russian Direct Investment Fund and Morepen Laboratories, one of the leading manufacturers of pharmaceutical products in India, today announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in state of Himachal Pradesh.
The first batch will be shipped to the Gamaleya Center for the quality control," the RDIF said in a press release.